"Phase II study of cilengitide in the treatment of refractory or relaps" by Tobey Macdonald, Gilbert Vezina et al.

Skip to main content

Radiology Faculty Publications

Title

Phase II study of cilengitide in the treatment of refractory or relapsed high-grade gliomas in children: A report from the Children's Oncology Group

Authors

Tobey Macdonald, Emory University
Gilbert Vezina, George Washington UniversityFollow
Clinton F. Stewart, St. Jude Children's Research Hospital, Memphis, TNFollow
David Turner, St. Jude Children's Research Hospital, Memphis, TN
Christopher R. Pierson, Ohio State University
Lu Chen, Children's Oncology Group, Arcadia, CA
Ian F. Pollack, University of Pittsburgh
Amar Gajjar, St. Jude Children's Research Hospital, Memphis, TN
Mark W. Kieran, Dana-Farber Children's Hospital Cancer Center, Boston, MA

Document Type

Journal Article

Publication Date

2013

Comments

PMCID: PMC3779033 [Available on 2014/10/1]

APA Citation

[Epub ahead of print]

Peer Reviewed

1

Link to Full Text

COinS